Market Newsdesk

NEW ALBANY, Ohio, April 23, 2025 (GLOBE NEWSWIRE) — Commercial Vehicle Group (the “Company” or “CVG”) (NASDAQ: CVGI) will hold its quarterly conference call on Wednesday, May 7, 2025, at 8:30 a.m. ET, to discuss first quarter 2025 financial results. CVG will issue a press release and presentation prior to the conference call.

Toll-free participants dial (800) 549-8228 using conference code 57416. International participants dial (289) 819-1520 using conference code 57416. This call is being webcast and can be accessed through the “Investors” section of CVG’s website at ir.cvgrp.com where it will be archived for one year.

A telephonic replay of the conference call will be available until May 21, 2025. To access the replay, toll-free callers can dial (+1) 888 660 6264 using access code 57416 #, and toll callers in North America and other locations can dial (+1) 289 819 1325.

About CVG

At CVG, we deliver real solutions to complex design, engineering and manufacturing problems while creating positive change for our customers, industries, and communities we serve. Information about the Company and its products is available on the internet at www.cvgrp.com.

Investor Relations Contact:

Ross Collins or Stephen Poe
Alpha IR Group
[email protected]

Presentations to underscore Allocetra^TM’s novel mechanism targeting immune imbalance in joint disease

Ness-Ziona, Israel, April 23, 2025 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that it will present two poster abstracts at the Osteoarthritis Research Society International (OARSI) 2025 World Congress on Osteoarthritis, taking place April 24-27, 2025, in Incheon (Seoul), South Korea.

“These presentations at OARSI 2025 will highlight the growing body of evidence supporting Allocetra’s^TM potential as a novel therapeutic approach for osteoarthritis,” said Oren Hershkovitz, PhD, Chief Executive Officer of Enlivex. “We believe that restoring macrophage homeostasis may address the underlying drivers of chronic joint inflammation and cartilage degradation, potentially offering a promising new treatment pathway for millions of patients worldwide.”

The presentations will feature data from both preclinical and clinical studies evaluating Allocetra™, Enlivex’s proprietary, off-the-shelf macrophage reprogramming cell therapy, in patients with osteoarthritis. Allocetra™ is designed to reprogram macrophages into a homeostatic state, thereby promoting immune balance and resolving chronic inflammation.

Allocetra™ has demonstrated favorable safety and promising efficacy signals in Phase I/II studies in moderate and end-stage osteoarthritis, including substantial and durable pain reduction, improved joint function, and avoidance of knee replacement surgery. Preclinical studies have further supported its unique mechanism of action in modulating macrophage-driven inflammation.

Accepted Presentations:

Flash Talk & Poster Presentation

• Title:
  Phase I/II Clinical Trial of Allocetra™ Cell Therapy for Knee Osteoarthritis: Initial Evidence of Response to Inflammation Modulation
• Abstract Publication Number: 092
• Flash Talk Session:
  Pain Mechanisms and Neuroinflammation in OA
• Date & Time: April 26, 2025 | 11:31 – 11:33 AM KST
• Poster Sessions:
  • Friday, April 25 | 4:15 – 5:00 PM KST
  • Saturday, April 26 | 4:15 – 5:00 PM KST
• Poster Number: 092

Poster Presentation

• Title:
  Biological Activity Characterization of Allocetra™, a Novel Macrophage Reprogramming Cell Therapy, in Osteoarthritis Preclinical Models
• Abstract Control ID: 4231304
• Poster Sessions:
  • Friday, April 25 | 3:30 – 4:15 PM KST
  • Saturday, April 26 | 3:30 – 4:15 PM KST
• Poster Number: 665

Dr. Oren Hershkovitz, CEO and Einat Galamidi, MD, CMO, will attend the conference and be available for meetings with stakeholders and members of the scientific community.

ABOUT ENLIVEX

Enlivex is a clinical stage macrophage reprogramming immunotherapy company developing Allocetra™, a universal, off-the-shelf cell therapy designed to reprogram macrophages into their homeostatic state. Resetting non-homeostatic macrophages into their homeostatic state is critical for immune system rebalancing and resolution of life-threatening and life debilitating conditions. For more information, visit http://www.enlivex.com.

Safe Harbor Statement:  This press release contains forward-looking statements, which may be identified by words such as “expects,” “plans,” “projects,” “will,” “may,” “anticipates,” “believes,” “should,” “would”, “could,” “intends,” “estimates,” “suggests,” “has the potential to” and other words of similar meaning, including statements regarding expected cash balances, market opportunities for the results of current clinical studies and preclinical experiments, the effectiveness of, and market opportunities for, ALLOCETRA 

^TM 

programs. All such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.  Investors are cautioned that forward-looking statements involve risks and uncertainties that may affect Enlivex’s business and prospects, including the risks that Enlivex may not succeed in generating any revenues or developing any commercial products; that the products in development may fail, may not achieve the expected results or effectiveness and/or may not generate data that would support the approval or marketing of these products for the indications being studied or for other indications; that ongoing studies may not continue to show substantial or any activity; and other risks and uncertainties that may cause results to differ materially from those set forth in the forward-looking statements. The results of clinical trials in humans may produce results that differ significantly from the results of clinical and other trials in animals. The results of early-stage trials may differ significantly from the results of more developed, later-stage trials. The development of any products using the ALLOCETRA 

^TM 

product line could also be affected by a number of other factors, including unexpected safety, efficacy or manufacturing issues, additional time requirements for data analyses and decision making, the impact of pharmaceutical industry regulation, the impact of competitive products and pricing and the impact of patents and other proprietary rights held by competitors and other third parties.  In addition to the risk factors described above, investors should consider the economic, competitive, governmental, technological and other factors discussed in Enlivex’s filings with the Securities and Exchange Commission, including in the Company’s most recent Annual Report on Form 20-F filed with the Securities and Exchange Commission.  The forward-looking statements contained in this press release speak only as of the date the statements were made, and we do not undertake any obligation to update forward-looking statements, except as required under applicable law.

Contact:

Dave Gentry, CEO
RedChip Companies, Inc.
1-407-644-4256
[email protected]   

BOCA RATON, Fla., April 23, 2025 (GLOBE NEWSWIRE) — Boca Raton, FL, April 23, 2025 – NewtekOne, Inc. (the “Company”) (NASDAQ: NEWT) announced that Peter Downs has been named President of Newtek Bank, N.A. (the “Bank”). In addition, Frank M. DeMaria has been named Chief Financial Officer of the Company, with Scott Price maintaining the role as Chief Financial Officer of Newtek Bank, focusing on developing and executing the Bank’s financial strategy.

Barry Sloane, CEO, President and Chairman, said, “We acquired National Bank of New York City on January 6, 2023, and, after a relatively condensed nine operating quarters, couldn’t be more pleased with our progress. We integrated and transformed a single-branch, OCC-chartered, manual-process bank in Flushing, NY, into what we believe to be a state-of-the-art, technology-enabled digital bank with a national presence. The Bank’s 42% efficiency ratio, 6% return on assets, and 40%+ return on tangible common equity for 2024 clearly speaks volumes of the management teams we have in place at the Company and the Bank. NewtekOne, established in 1998 and publicly traded since September 2000, has never been an organization to sit and rest on its history or its laurels. In addition to the promotions of Peter Downs and Frank DeMaria, we have promoted Thomas Soucy to Chief Credit Officer of the Bank, Nicholas Leger to CFO of a number of our non-bank subsidiaries and added Andrew Kaplan, our Chief Strategy Officer, to the board of the Bank. We have enacted these management changes to prepare NewtekOne for its next chapter of growth, which will continue to rely on our in-house developed applications – The Newtek Advantage^®, NewTracker^®, and secure Newtek File Vault™ – to provide our independent business owner clients with superior business and financial solutions on demand and by on-camera staff available 24/7/365. I am particularly excited for Peter Downs to take the helm at Newtek Bank. In July of this year, Pete will be celebrating his 22^nd anniversary with the Company and has played an instrumental role in helping to build our technology-enabled platform and strategy.”

Mr. Sloane continued, “We will continue to make management changes with a focus on helping to grow and shape the Company in our quest to embrace technology and provide financial and business solutions to our independent business owner clients. We are also thrilled to have, today, reported another successful ALP securitization and look forward to reporting and discussing our quarterly financial results and anticipated progress for the rest of 2025.”

About NewtekOne, Inc.

NewtekOne

^®
, Your Business Solutions Company^®, is a financial holding company, which along with its bank and non-bank consolidated subsidiaries (collectively, “NewtekOne”), provides a wide range of business and financial solutions under the Newtek^® brand to independent business owners. Since 1999, NewtekOne has provided state-of-the-art, cost-efficient products and services and efficient business strategies to independent business owners across all 50 states to help them grow their sales, control their expenses, and reduce their risk.

NewtekOne’s and its subsidiaries’ business and financial solutions include: banking (Newtek Bank, N.A.), Business Lending, SBA Lending Solutions, Electronic Payment Processing, Accounts Receivable Financing & Inventory Financing, Insurance Solutions and Payroll and Benefits Solutions. In addition, NewtekOne offers its clients the Technology Solutions (Cloud Computing, Data Backup, Storage and Retrieval, IT Consulting and Web Services) provided by Intelligent Protection Management Corp. (IPM.com).

Newtek

^®
, NewtekOne^®, Newtek Bank^®, National Association, Your Business Solutions Company^®, One Solution for All Your Business Needs^® and Newtek Advantage are registered trademarks of NewtekOne, Inc.

Note Regarding Forward-Looking Statements

Certain statements in this press release are “forward-looking statements” within the meaning of the rules and regulations of the Private Securities Litigation and Reform Act of 1995 are based on the current beliefs and expectations of NewtekOne’s management and are subject to significant risks and uncertainties. Actual results may differ materially from those set forth in the forward-looking statements.  Information regarding
loan and deposit metrics
consist of preliminary estimates and are subject to change with our filings with regulatory agencies and the filing of the Company’s Form 10-Q for the period ended March 31, 2025.  See “Note Regarding Forward-Looking Statements” and the sections entitled “Risk Factors” in our filings with the Securities and Exchange Commission which are available on NewtekOne’s website (https://investor.newtekbusinessservices.com/sec-filings) and on the Securities and Exchange Commission’s website (www.sec.gov). Any forward-looking statements made by or on behalf of NewtekOne speak only as to the date they are made, and NewtekOne does not undertake to update forward-looking statements to reflect the impact of circumstances or events that arise after the date the forward-looking statements were made.

SOURCE: NewtekOne, Inc.

Investor Relations & Public Relations


Contact: Bryce Rowe
Telephone: (212) 273-8292 / [email protected]

MIAMI and NEW YORK, April 23, 2025 (GLOBE NEWSWIRE) —  Siebert Financial Corp. (NASDAQ: SIEB), a diversified financial services company, has appointed Stefano Marrone as Chief Marketing Officer. Marrone will direct marketing for all divisions (including Siebert.Valor, Siebert.SPS, and Gebbia Media) to advance the firm’s mission of delivering “Financial Freedom for Everyone.” A key focus of his role will be bringing media production and financial literacy together, leveraging the unique presence of Gebbia Media within Siebert Financial.

In 2024, Marrone led Siebert Financial’s successful rebrand and rolled out a modernized website as a consultant, working closely with Siebert’s leadership. That initiative drove notable brand growth and client engagement. He brings extensive experience collaborating with leading financial institutions such as J.P. Morgan, UBS Asset Management, and HSBC, as well as tech giants Google and Meta. Marrone also founded and exited a content agency, demonstrating an entrepreneurial spirit that fuels bold marketing and strategic thinking.

“Stefano’s ability to deliver fresh thinking has already energized Siebert Financial,” said John J Gebbia, CEO of Siebert Financial. “He helped spark our rebrand last year, and we’re excited about his vision to engage the next generation of investors, which will keep us ahead in a competitive market.”

Marrone will focus on creative campaigns, AI-driven marketing, and brand development. He aims to build innovative content solutions that increase both financial literacy and client engagement, particularly through Gebbia Media’s production capabilities.

“Stefano’s commitment to modern content resonates with our goals,” said David Gebbia, Principal at Siebert Financial and CEO of Gebbia Media. “Bringing together media production and financial education under one roof is a rare advantage for a financial firm. His background in storytelling and AI will help us create dynamic content, bridging entertainment and financial literacy for clients of all ages.”

Siebert.Valor’s mission to reach veterans and military families remains key to the company. Marrone will ensure messaging and educational resources reach those audiences effectively, reflecting the firm’s broader commitment to inclusivity.

“Stefano has a gift for making complex topics like financial education feel clear and empowering. His approach will help us better support our veterans and active-duty communities,” said Kaj Larsen, Head of Military Investment and Communications at Siebert.

Marrone sees bold leadership and unified media resources as keys to building on Siebert Financial’s legacy of innovation in finance.

“I am excited to join a financial brand with such a rich history,” said Marrone. “Working with the Gebbia family has shown me how forward-looking leadership can reimagine a legacy institution. Combining Gebbia Media’s creative capabilities with robust financial education to engage with a younger audience segment is a powerful strategy. I’m honored to help shape the next chapter of Siebert Financial as we continue to innovate in an industry that strongly needs it.”

About Siebert Financial Corp.

Siebert is a diversified financial services company and has been a member of the NYSE since 1967, when Muriel Siebert became the first woman to own a seat on the NYSE and the first to head one of its member firms.

Siebert operates through its subsidiaries Muriel Siebert & Co., LLC, Siebert AdvisorNXT, LLC, Park Wilshire Companies, Inc., RISE Financial Services, LLC, Siebert Technologies, LLC, and StockCross Digital Solutions, Ltd, and Gebbia Entertainment LLC. Through these entities, Siebert provides a full range of brokerage and financial advisory services, including securities brokerage, investment advisory and insurance offerings, securities lending, and corporate stock plan administration solutions, in addition to entertainment and media productions. For over 55 years, Siebert has been a company that values its clients, shareholders, and employees. More information is available at www.siebert.com.

About Gebbia Media
Gebbia Media is a subsidiary of Siebert Financial Corp. and is an entertainment company focused on the promotion of music artists and catalogue acquisition, as well as the production of film and TV content across story-driven, reality, and factual formats. Gebbia Media functions as the in-house production agency of Siebert Financial and currently has several media projects in development.

Cautionary Note Regarding Forward-Looking Statements

The statements contained in this press release that are not historical facts, including statements about our beliefs and expectations, are “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements preceded by, followed by, or that include the words “may,” “could,” “would,” “should,” “believe,” “expect,” “anticipate,” “plan,” “estimate,” “target,” “project,” “intend” and similar words or expressions. In addition, any statements that refer to expectations, projections, or other characterizations of future events or circumstances are forward-looking statements.

These forward-looking statements, which reflect beliefs, objectives, and expectations as of the date hereof, are based on the best judgment of the management of Siebert. All forward-looking statements speak only as of the date on which they are made. Such forward-looking statements are subject to certain risks, uncertainties and assumptions relating to factors that could cause actual results to differ materially from those anticipated in such statements, including, without limitation, the following: economic, social and political conditions, global economic downturns resulting from extraordinary events; securities industry risks; interest rate risks; liquidity risks; credit risk with clients and counterparties; risk of liability for errors in clearing functions; systemic risk; systems failures, delays and capacity constraints; network security risks; competition; reliance on external service providers; new laws and regulations affecting Siebert’s business; net capital requirements; extensive regulation, regulatory uncertainties and legal matters; failure to maintain relationships with employees, customers, business partners or governmental entities; the inability to achieve synergies or to implement integration plans; and other consequences associated with risks and uncertainties detailed in Part I, Item 1A – Risk Factors of Siebert’s Annual Report on Form 10-K for the year ended December 31, 2023, and Siebert’s filings with the SEC.

Siebert cautions that the foregoing list of factors is not exclusive, and new factors may emerge, or changes to the foregoing factors may occur that could impact its business. Siebert undertakes no obligation to publicly update or revise these statements, whether as a result of new information, future events, or otherwise, except to the extent required by the federal securities laws.

Media Contact

Deborah Kostroun, Zito Partners
[email protected]
+1 (201) 403-8185

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/a0d77ebc-7226-46ce-8c2e-5129bfd3057d